Dostinex Side Effects

Name: Dostinex

Generic: Cabergoline

Manufacturer: Pfizer

Date approved: December 23, 1996

Status: Prescription only

Approved uses: Approved for the treatment of hyperprolactinemic disorders,either idiopathic or due to pituitary adenomas.

Off-Label uses: It has at times been used as an adjunct to SSRI antidepressants as there is some evidence that it counteracts certain side effects of those drugs, such as reduced libido and anorgasmia

Side effects:
  • Unusual weakness or fatigue
  • nausea or vomiting
  • constipation
  • headache
  • dizziness
  • drowsiness
  • tingling or numbness sensations
  • mental or mood changes
  • fainting
  • swelling of feet or ankles
  • breast pain
  • menstrual changes
  • vision problems
  • as well as possible link to valvular heart disease.
Related topics: Pergolide


Dostinex

Dostinex, also known by the generic name of its active ingredient Cabergoline, is a prescription medication used to treat certain hormone problems involving excess prolactin. The drug is also used to reduce or prevent breast milk production, except after childbirth (postpartum). In addition, this drug may also be used to treat Parkinson's disease in some cases, treat prolactin-producing tumors and to adjust various hormone levels in certain diseases (ovarian diseases). Side effects of the drug can include unusual weakness or fatigue, nausea or vomiting, constipation, headache, dizziness, drowsiness, tingling or numbness sensation may occur. If these persist or worsen, notify your doctor. Unlikely side effects that should also be reported promptly can include mental or mood changes, fainting, swelling of feet or ankles, breast pain, menstrual changes, vision problems. In addition to these side effects, in two studies published in the New England Journal of Medicine on January 4, 2007, Dostinex was implicated along with pergolide in causing valvular heart disease in some patients. Both drugs are ergot-derived dopamine agonists, although their molecular skeletons are different. As a result of this, the Food and Drug Administration removed pergolide from the U.S. market on March 29, 2007. Dostinex is approved in the U.S. for the treatment of hyperprolactinemic disorders (conditions in which there are elevated levels of prolactin in the blood).  Dostinex is not approved in the U.S. for the treatment of Parkinson’s disease.  For hyperprolactinemic disorders, a considerably lower dose of Dostinex is used.  At these lower doses of Dostinex, there appears to be little chance of heart problems, therefore Dostinex remains on the US market for the treatment of hyperprolactinemic disorders. However, any patients who have received Dostinex as a treatment for Parkinson's should consult with their physician as to whether the dosage of the drug they received may contribute to valvular heart disease. If you or someone you know may have been negatively affected by the possible side effects of Dostinex, use the Dostinex attorney case evaluation form on this page to be contacted by an experienced Dostinex attorney as soon as possible.



Dostinex News Articles

Hyperprolactinemia Diagnosis Sufficient With Single Test - Guidelines recommend treatment with dopamine agonist therapy, discourage dynamic testing - ModernMedicine

The girl in the window - CharlotteObserver.com

View the Dostinex News Articles page here


Dostinex Newsfeeds

This bud's for you? Medical marijuana discussions heat up in Michigan

Parkinson's drug side effects turns IT manager into sex-crazed transvestite

View the Dostinex Newsfeeds page here

Need A Dostinex Attorney?

First Name Last Name Email Address State
Was Your Health Negatively Affected?

Please Describe the Injury

Your Friend's Email Address

Your Email Address

Type a Message (optional)


 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Dostinex Case - Submit Your Information Below

Do you need legal assistance with your Dostinex case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * Unsafe Drugs: Dostinex Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.